Medical composition containing stauntonia hexaphylla extract

Abstract

Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.

What is claimed is: 
     
         1 . An anti-inflammatory composition comprising a  Stauntonia Hexaphylla  fraction obtained by fractionating a  Stauntonia Hexaphylla  leaf water extract with ethyl acetate or chloroform as a fractionation solvent leaf hot water extract as an active ingredient and a pharmaceutically acceptable carrier. 
     
     
         2 . A cosmetic composition for relieving or alleviating inflammation comprising a  Stauntonia Hexaphylla  fraction obtained by fractionating a  Stauntonia Hexaphylla  leaf water extract with ethyl acetate or chloroform as a fractionation solvent as an active ingredient and a pharmaceutically acceptable carrier. 
     
     
         3 . An anti-pyretic composition comprising a  Stauntonia Hexaphylla  fraction obtained by fractionating a  Stauntonia Hexaphylla  leaf water extract with chloroform or ethyl acetate as a fractionation solvent leaf hot water extract as an active ingredient and a pharmaceutically acceptable carrier. 
     
     
         4 . Method of inflammation treatment comprising administering a composition comprising a  Stauntonia Hexaphylla  fraction as an active ingredient obtained by fractionating a  Stauntonia Hexaphylla  leaf water extract with ethyl acetate or chloroform as a fractionation solvent, and a pharmaceutically acceptable carrier. 
     
     
         5 . Method of anti-pyretic treatment comprising administering a composition comprising  Stauntonia Hexaphylla  fraction as an active ingredient obtained by fractionating a  Stauntonia Hexaphylla  leaf water extract with ethyl acetate or chloroform as a fractionation solvent, and a pharmaceutically acceptable carrier.